| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034704679 |
| P356 | DOI | 10.1038/KI.2015.146 |
| P932 | PMC publication ID | 4558568 |
| P698 | PubMed publication ID | 25993320 |
| P5875 | ResearchGate publication ID | 277084333 |
| P2093 | author name string | Josep M Aran | |
| Josep M Cruzado | |||
| Josep M Grinyó | |||
| Marc Lúcia | |||
| Ana Merino | |||
| Juan Torras | |||
| Laura de Ramon | |||
| Elia Ripoll | |||
| Nuria Lloberas | |||
| S Pérez-Rentero | |||
| P2860 | cites work | Human galectin-3 is a novel chemoattractant for monocytes and macrophages | Q22254736 |
| Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus | Q24301114 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Delayed graft function in the kidney transplant | Q26824506 | ||
| CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms | Q28533954 | ||
| Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis | Q30497499 | ||
| Chemical modification: the key to clinical application of RNA interference? | Q33308712 | ||
| CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury | Q33585866 | ||
| Chemokines in ischemia and reperfusion | Q80265485 | ||
| Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function | Q80768748 | ||
| Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow | Q80971468 | ||
| CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling | Q81724807 | ||
| Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury | Q81737588 | ||
| The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity | Q33938693 | ||
| Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney | Q33948196 | ||
| Efficient and targeted delivery of siRNA in vivo | Q34149828 | ||
| The T cell as a bridge between innate and adaptive immune systems: implications for the kidney | Q34655612 | ||
| Monocytes in the rat: phenotype and function during acute allograft rejection | Q34709483 | ||
| Gene silencing in mammals by small interfering RNAs | Q34931992 | ||
| The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses | Q35751635 | ||
| Ischemic acute renal failure: an inflammatory disease? | Q35836380 | ||
| T cells as mediators in renal ischemia/reperfusion injury. | Q35836389 | ||
| Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury | Q36114632 | ||
| Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure | Q36169286 | ||
| Renal ischemia-reperfusion injury amplifies the humoral immune response | Q36977339 | ||
| Functions of S100 proteins. | Q37001259 | ||
| The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury | Q37371904 | ||
| Galectins in the Pathogenesis of Rheumatoid Arthritis | Q37457505 | ||
| SOCS3, a Major Regulator of Infection and Inflammation. | Q37592325 | ||
| TLR2 and TLR4 in ischemia reperfusion injury | Q37772401 | ||
| S100A proteins as molecular targets in the ocular surface inflammatory diseases. | Q38179570 | ||
| Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates | Q39640425 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Leukocytes, cell adhesion molecules and ischemic acute renal failure | Q41469756 | ||
| Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
| TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic | Q42004462 | ||
| Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury | Q42613092 | ||
| Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? | Q42702615 | ||
| Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction | Q44762410 | ||
| Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates | Q44765909 | ||
| Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs | Q45147309 | ||
| Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy | Q45235006 | ||
| In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection | Q45869121 | ||
| A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury | Q46461255 | ||
| Increased TNF expression in CD43++ murine blood monocytes. | Q50062017 | ||
| The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. | Q50551664 | ||
| Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. | Q52968716 | ||
| Ablation of proximal tubular suppressor of cytokine signaling 3 enhances tubular cell cycling and modifies macrophage phenotype during acute kidney injury. | Q53074044 | ||
| CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury | Q56908099 | ||
| Role of Cold Ischemia in Acute Rejection: Characterization of a Humoral-Like Acute Rejection in Experimental Renal Transplantation | Q59491287 | ||
| Galectin-3 promotes adhesion of human neutrophils to laminin | Q71059473 | ||
| Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions | Q73812280 | ||
| The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells | Q74464420 | ||
| Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury | Q80142589 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 538-549 | |
| P577 | publication date | 2015-05-20 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | CD154-CD40 T-cell co-stimulation pathway is a key mechanism in kidney ischemia-reperfusion injury | |
| P478 | volume | 88 |
| Q89848603 | CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine |
| Q37375148 | Costimulation Blockade in Kidney Transplantation: An Update |
| Q64071623 | FTY720 Effects on Inflammation and Liver Damage in a Rat Model of Renal Ischemia-Reperfusion Injury |
| Q47102162 | Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function |
| Q55162275 | The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response? |
| Q92340246 | The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE -/- mice |
| Q88671029 | The role of platelets in acute kidney injury |
| Q64120598 | siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice |
Search more.